CVS Well being companions with ixlayer for branded at-home testing kits

1

[ad_1]

Digital diagnostics firm ixlayer introduced it’s going to produce CVS Well being’s branded at-home pattern assortment kits. 

ixlayer’s kits can check for Lyme illness, Vitamin D ranges, thyroid perform and sexually-transmitted infections. Customers are additionally supplied training and details about what the outcomes imply. 

Shoppers can now buy the CVS Well being-branded checks on-line or decide up a check in-store at choose CVS areas. 

As soon as bought, the tester prompts their account and sends their pattern in a pay as you go mailer. By way of ixlayer, check outcomes are supplied to shoppers through an internet portal. 

“With almost 70% of medical selections depending on lab testing, common diagnostic testing is a cornerstone of bettering well being and wellness,” Pouria Sanae, CEO and cofounder of ixlayer, stated in a press release. “At-home testing permits individuals to proactively take management of their well being, on their very own schedule, within the privateness of their very own house and regularly.”

THE LARGER TREND

The at-home testing market has grown and buyers have taken discover. 

Morgan Well being, JP Morgan Chase’s healthcare enterprise unit, introduced a $20 million strategic funding in LetsGetChecked, an organization providing at-home testing for sexual well being, diabetes, fertility hormones, ldl cholesterol and COVID-19.

LetsGetChecked closed a $150 million Sequence D spherical in 2021, constructing on raises in 2018, 2019 and 2020. 

In April, diagnostics large Labcorp partnered with Getlabs to supply at-home pattern assortment for lab checks.

The service, Getlabs for Labcorp, permits customers to schedule an appointment on-line for an at-home blood draw. A phlebotomist can accumulate samples of saliva, stool, urine and breath, and measure very important indicators. The gathering prices a comfort payment beginning at $25. 

Fla.-based Getlabs, which additionally delivers specimens for Quest Diagnostics, scored $20 million in Sequence A financing earlier this yr. 

[ad_2]
Source link